SUPPLEMENT
Q3 2020 — Sales of Key Products/Franchises
Q3 2020PDF · 4 pages214 KB
REPORTED SALES vs. PRIOR PERIOD ($MM) REPORTED SALES vs. PRIOR PERIOD ($MM) THIRD QUARTER NINE MONTHS 2020 2019 Reported Operational (1) Currency 2020 2019 Reported Operational (1) Currency CONSUMER HEALTH SEGMENT (2,3) OTC US 601 $ 477 26.0% 26.0% - 1,917 $ 1,468 30.6% 30.6% - Intl 541 621 -12.9% -12.9% 0.0% 1,722 1,781 -3.3% -0.6% -2.7% WW 1,142 1,098 4.0% 4.0% 0.0% 3,639 3,249 12.0% 13.5% -1.5% SKIN HEALTH / BEAUTY (4) US 572 559 2.4% 2.4% - 1,767 1,810 -2.4% -2.4% - Intl 577 592 -2.7% -0.5% -2.2% 1,506 1,633 -7.8% -4.9% -2.9% WW 1,149 1,151 -0.2% 0.9% -1.1% 3,273 3,443 -5.0% -3.6% -1.4% ORAL CARE US 164 156 5.5% 5.5% - 510 462 10.4% 10.4% - Intl 248 223 10.7% 14.4% -3.7% 694 673 3.0% 7.9% -4.9% WW 412 379 8.5% 10.8% -2.3% 1,204 1,135 6.0% 8.9% -2.9% BABY CARE US 91 91 -1.0% -1.0% - 279 277 0.5% 0.5% - Intl 302 326 -7.2% -0.6% -6.6% 831 977 -14.9% -8.6% -6.3% WW 393 417 -5.9% -0.7% -5.2% 1,110 1,254 -11.5% -6.6% -4.9% WOMEN'S HEALTH US 3 3 -6.9% -6.9% - 10 9 7.3% 7.3% - Intl 227 252 -9.6% -4.0% -5.6% 654 724 -9.6% -2.8% -6.8% WW 230 255 -9.6% -4.1% -5.5% 664 733 -9.4% -2.7% -6.7% WOUND CARE / OTHER US 125 109 15.2% 15.2% - 370 343 8.0% 8.0% - Intl 64 59 7.4% 10.3% -2.9% 175 173 1.3% 5.4% -4.1% WW 189 168 12.5% 13.5% -1.0% 545 516 5.8% 7.2% -1.4% TOTAL CONSUMER HEALTH US 1,556 1,394 11.6% 11.6% - 4,853 4,369 11.1% 11.1% - Intl 1,958 2,075 -5.6% -2.7% -2.9% 5,582 5,962 -6.4% -2.2% -4.2% WW 3,514 $ 3,469 1.3% 3.0% -1.7% 10,435 $ 10,331 1.0% 3.4% -2.4% See footnotes at end of schedule % Change % Change -- 1 of 4 -- REPORTED SALES vs. PRIOR PERIOD ($MM) REPORTED SALES vs. PRIOR PERIOD ($MM) THIRD QUARTER NINE MONTHS PHARMACEUTICAL SEGMENT (2,5) 2020 2019 Reported Operational (1) Currency 2020 2019 Reported Operational (1) Currency IMMUNOLOGY US 2,558 $ 2,582 -0.9% -0.9% - 7,330 $ 7,124 2.9% 2.9% - Intl 1,230 1,129 9.0% 8.4% 0.6% 3,619 3,304 9.5% 11.9% -2.4% WW 3,789 3,711 2.1% 1.9% 0.2% 10,950 10,428 5.0% 5.7% -0.7% REMICADE US 634 749 -15.4% -15.4% - 1,852 2,324 -20.3% -20.3% - US Exports (6) 78 88 -11.3% -11.3% - 321 226 42.1% 42.1% - Intl 209 299 -30.1% -28.0% -2.1% 673 795 -15.3% -11.6% -3.7% WW 921 1,136 -18.9% -18.4% -0.5% 2,846 3,345 -14.9% -14.0% -0.9% SIMPONI / SIMPONI ARIA US 312 313 -0.4% -0.4% - 840 857 -2.0% -2.0% - Intl 280 273 2.4% 2.2% 0.2% 827 816 1.3% 3.9% -2.6% WW 592 586 0.9% 0.8% 0.1% 1,667 1,673 -0.4% 0.9% -1.3% STELARA US 1,313 1,212 8.4% 8.4% - 3,668 3,152 16.4% 16.4% - Intl 634 487 30.3% 28.1% 2.2% 1,795 1,509 19.0% 20.6% -1.6% WW 1,947 1,698 14.7% 14.0% 0.7% 5,463 4,661 17.2% 17.7% -0.5% TREMFYA US 222 221 0.4% 0.4% - 650 565 15.0% 15.0% - Intl 105 69 54.4% 50.4% 4.0% 316 177 78.7% 79.1% -0.4% WW 327 290 13.1% 12.2% 0.9% 965 742 30.2% 30.3% -0.1% OTHER IMMUNOLOGY US - - - - - - - - - - Intl 3 2 35.6% 44.6% -9.0% 9 8 12.4% 19.1% -6.7% WW 3 2 35.6% 44.6% -9.0% 9 8 12.4% 19.1% -6.7% INFECTIOUS DISEASES US 413 418 -1.1% -1.1% - 1,265 1,162 8.9% 8.9% - Intl 451 421 7.0% 6.3% 0.7% 1,397 1,385 0.9% 3.8% -2.9% WW 864 839 3.0% 2.6% 0.4% 2,662 2,547 4.5% 6.1% -1.6% EDURANT / rilpivirine US 11 12 -12.0% -12.0% - 33 36 -8.6% -8.6% - Intl 226 206 9.3% 5.0% 4.3% 684 603 13.3% 13.8% -0.5% WW 236 218 8.1% 4.1% 4.0% 716 639 12.1% 12.6% -0.5% PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA US 379 373 1.5% 1.5% - 1,154 1,032 11.8% 11.8% - Intl 147 135 9.1% 12.1% -3.0% 461 534 -13.7% -8.8% -4.9% WW 526 508 3.5% 4.3% -0.8% 1,615 1,566 3.1% 4.8% -1.7% OTHER INFECTIOUS DISEASES US 24 33 -26.6% -26.6% - 79 94 -16.6% -16.6% - Intl 78 80 -2.3% -0.4% -1.9% 252 248 1.8% 6.3% -4.5% WW 102 113 -9.4% -8.1% -1.3% 331 342 -3.2% 0.0% -3.2% % Change % Change -- 2 of 4 -- REPORTED SALES vs. PRIOR PERIOD ($MM) REPORTED SALES vs. PRIOR PERIOD ($MM) THIRD QUARTER NINE MONTHS 2020 2019 Reported Operational (1) Currency 2020 2019 Reported Operational (1) Currency NEUROSCIENCE US 759 785 -3.5% -3.5% - 2,285 2,172 5.2% 5.2% - Intl 846 810 4.5% 4.1% 0.4% 2,565 2,590 -1.0% 0.9% -1.9% WW 1,605 1,595 0.6% 0.4% 0.2% 4,850 4,762 1.8% 2.9% -1.1% CONCERTA / Methylphenidate US 43 84 -49.2% -49.2% - 150 196 -23.6% -23.6% - Intl 107 109 -2.0% -1.7% -0.3% 319 348 -8.2% -6.4% -1.8% WW 149 193 -22.6% -22.5% -0.1% 469 544 -13.8% -12.6% -1.2% INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA US 585 554 5.6% 5.6% - 1,704 1,543 10.5% 10.5% - Intl 341 297 14.9% 12.6% 2.3% 983 916 7.3% 8.6% -1.3% WW 926 851 8.8% 8.0% 0.8% 2,688 2,459 9.3% 9.8% -0.5% RISPERDAL CONSTA US 70 79 -11.0% -11.0% - 220 237 -6.9% -6.9% - Intl 81 89 -7.8% -8.9% 1.1% 254 292 -12.7% -11.0% -1.7% WW 152 167 -9.3% -9.9% 0.6% 475 528 -10.1% -9.2% -0.9% OTHER NEUROSCIENCE US 60 68 -11.3% -11.3% - 210 196 7.1% 7.1% - Intl 317 316 0.3% 1.7% -1.4% 1,008 1,035 -2.6% -0.1% -2.5% WW 377 384 -1.8% -0.6% -1.2% 1,218 1,231 -1.1% 1.1% -2.2% ONCOLOGY US 1,267 1,171 8.2% 8.2% - 3,623 3,146 15.2% 15.2% - Intl 1,862 1,590 17.1% 15.5% 1.6% 5,310 4,830 9.9% 11.8% -1.9% WW 3,129 2,761 13.3% 12.4% 0.9% 8,933 7,976 12.0% 13.1% -1.1% DARZALEX US 585 402 46.0% 46.0% - 1,540 1,123 37.2% 37.2% - Intl 514 363 41.5% 40.5% 1.0% 1,397 1,045 33.7% 36.7% -3.0% WW 1,099 765 43.8% 43.4% 0.4% 2,937 2,168 35.5% 37.0% -1.5% ERLEADA US 152 74 * * - 407 194 * * - Intl 55 12 * * * 112 22 * * * WW 206 86 * * * 519 216 * * * IMBRUVICA US 450 447 0.7% 0.7% - 1,329 1,163 14.2% 14.2% - Intl 581 475 22.5% 21.2% 1.3% 1,682 1,373 22.5% 25.2% -2.7% WW 1,031 921 11.9% 11.2% 0.7% 3,011 2,536 18.7% 20.2% -1.5% VELCADE US - - - - - - - - - - Intl 105 149 -30.1% -30.8% 0.7% 311 636 -51.2% -50.7% -0.5% WW 105 149 -30.1% -30.8% 0.7% 311 636 -51.2% -50.7% -0.5% ZYTIGA / abiraterone acetate US 58 233 -75.2% -75.2% - 284 616 -53.9% -53.9% - Intl 532 508 4.8% 2.2% 2.6% 1,564 1,502 4.1% 4.8% -0.7% WW 590 741 -20.4% -22.1% 1.7% 1,848 2,118 -12.7% -12.3% -0.4% OTHER ONCOLOGY US 21 17 35.3% 35.3% - 63 51 25.8% 25.8% - Intl 76 83 -8.8% -10.1% 1.3% 244 252 -3.1% -1.1% -2.0% WW 98 100 -1.7% -2.8% 1.1% 308 303 1.7% 3.3% -1.6% PULMONARY HYPERTENSION US 510 427 19.4% 19.4% - 1,541 1,296 18.9% 18.9% - Intl 239 227 5.2% 3.7% 1.5% 742 704 5.3% 6.5% -1.2% WW 749 654 14.5% 13.9% 0.6% 2,283 2,000 14.1% 14.6% -0.5% OPSUMIT US 244 206 18.1% 18.1% - 729 581 25.3% 25.3% - Intl 148 140 5.5% 3.9% 1.6% 458 419 9.3% 10.7% -1.4% WW 392 347 13.0% 12.3% 0.7% 1,187 1,001 18.6% 19.2% -0.6% UPTRAVI US 226 185 22.4% 22.4% - 692 536 29.1% 29.1% - Intl 34 25 32.3% 28.9% 3.4% 100 75 33.1% 34.6% -1.5% WW 260 210 23.6% 23.2% 0.4% 792 611 29.6% 29.8% -0.2% OTHER PULMONARY HYPERTENSION US 40 36 11.5% 11.5% - 121 179 -32.3% -32.3% - Intl 57 61 -6.7% -7.4% 0.7% 183 210 -12.7% -11.9% -0.8% WW 97 96 0.1% -0.3% 0.4% 304 388 -21.7% -21.3% -0.4% CARDIOVASCULAR / METABOLISM / OTHER US 931 955 -2.6% -2.6% - 2,574 2,804 -8.2% -8.2% - Intl 351 360 -2.7% -2.4% -0.3% 1,052 1,131 -7.1% -4.6% -2.5% WW 1,281 1,316 -2.6% -2.5% -0.1% 3,625 3,936 -7.9% -7.2% -0.7% XARELTO US 630 613 2.9% 2.9% - 1,716 1,704 0.7% 0.7% - Intl - - - - - - - - - - WW 630 613 2.9% 2.9% - 1,716 1,704 0.7% 0.7% - INVOKANA / INVOKAMET US 156 125 24.7% 24.7% - 405 411 -1.6% -1.6% - Intl 68 55 24.7% 25.2% -0.5% 173 147 18.0% 20.7% -2.7% WW 224 179 24.7% 24.9% -0.2% 578 558 3.6% 4.3% -0.7% PROCRIT / EPREX US 69 126 -45.4% -45.4% - 215 387 -44.5% -44.5% - Intl 63 72 -12.2% -13.0% 0.8% 208 220 -5.5% -4.3% -1.2% WW 132 198 -33.3% -33.6% 0.3% 423 607 -30.4% -29.9% -0.5% OTHER US 75 91 -17.9% -17.9% - 238 302 -21.4% -21.4% - Intl 219 234 -6.2% -5.5% -0.7% 670 765 -12.3% -9.5% -2.8% WW 294 325 -9.5% -9.0% -0.5% 908 1,067 -14.9% -12.9% -2.0% TOTAL PHARMACEUTICAL US 6,438 6,340 1.5% 1.5% - 18,619 17,705 5.2% 5.2% - Intl 4,980 4,537 9.7% 8.8% 0.9% 14,685 13,945 5.3% 7.4% -2.1% WW 11,418 $ 10,877 5.0% 4.6% 0.4% 33,304 $ 31,650 5.2% 6.1% -0.9% See footnotes at end of schedule % Change % Change -- 3 of 4 -- REPORTED SALES vs. PRIOR PERIOD ($MM) REPORTED SALES vs. PRIOR PERIOD ($MM) THIRD QUARTER NINE MONTHS MEDICAL DEVICES SEGMENT (2,5) 2020 2019 Reported Operational (1) Currency 2020 2019 Reported Operational (1) Currency INTERVENTIONAL SOLUTIONS US 399 357 11.8% 11.8% - 1,019 1,066 -4.4% -4.4% - Intl 437 382 14.0% 12.9% 1.1% 1,134 1,156 -2.0% -1.0% -1.0% WW 836 741 12.9% 12.4% 0.5% 2,153 2,223 -3.1% -2.7% -0.4% ORTHOPAEDICS US 1,308 1,301 0.6% 0.6% - 3,427 3,950 -13.2% -13.2% - Intl 774 837 -7.5% -9.0% 1.5% 2,145 2,616 -18.0% -16.9% -1.1% WW 2,083 2,138 -2.6% -3.1% 0.5% 5,572 6,566 -15.1% -14.7% -0.4% HIPS US 221 204 8.7% 8.7% - 564 633 -10.9% -10.9% - Intl 124 133 -7.2% -8.4% 1.2% 344 428 -19.8% -18.3% -1.5% WW 345 336 2.4% 1.9% 0.5% 908 1,061 -14.5% -13.9% -0.6% KNEES US 205 209 -1.9% -1.9% - 527 650 -19.0% -19.0% - Intl 102 136 -24.8% -26.4% 1.6% 298 435 -31.5% -30.7% -0.8% WW 308 344 -10.9% -11.6% 0.7% 825 1,085 -24.0% -23.7% -0.3% TRAUMA US 433 415 4.2% 4.2% - 1,194 1,239 -3.6% -3.6% - Intl 253 262 -3.4% -4.7% 1.3% 698 795 -12.2% -10.9% -1.3% WW 685 677 1.3% 0.7% 0.6% 1,892 2,034 -7.0% -6.5% -0.5% SPINE, SPORTS & OTHER (7) US 449 472 -4.9% -4.9% - 1,142 1,427 -20.0% -20.0% - Intl 295 306 -3.4% -5.0% 1.6% 805 957 -15.8% -14.9% -0.9% WW 745 778 -4.3% -5.0% 0.7% 1,947 2,384 -18.3% -18.0% -0.3% SURGERY US 913 940 -3.0% -3.0% - 2,247 2,867 -21.7% -21.7% - Intl 1,239 1,371 -9.6% -9.5% -0.1% 3,556 4,192 -15.2% -13.1% -2.1% WW 2,152 2,311 -6.9% -6.9% 0.0% 5,803 7,059 -17.8% -16.6% -1.2% ADVANCED US 421 409 3.0% 3.0% - 1,079 1,209 -10.7% -10.7% - Intl 579 602 -3.9% -4.1% 0.2% 1,644 1,811 -9.2% -7.3% -1.9% WW 1,000 1,010 -1.1% -1.2% 0.1% 2,723 3,019 -9.8% -8.7% -1.1% GENERAL US 492 531 -7.6% -7.6% - 1,168 1,658 -29.6% -29.6% - Intl 660 769 -14.1% -13.8% -0.3% 1,912 2,381 -19.7% -17.5% -2.2% WW 1,152 1,301 -11.4% -11.3% -0.1% 3,080 4,040 -23.8% -22.5% -1.3% VISION US 473 459 3.1% 3.1% - 1,160 1,366 -15.1% -15.1% - Intl 608 734 -17.2% -17.4% 0.2% 1,683 2,117 -20.5% -19.6% -0.9% WW 1,081 1,193 -9.4% -9.5% 0.1% 2,843 3,483 -18.4% -17.8% -0.6% CONTACT LENSES / OTHER US 375 339 10.9% 10.9% - 924 993 -6.9% -6.9% - Intl 455 555 -18.1% -18.2% 0.1% 1,274 1,566 -18.7% -17.8% -0.9% WW 830 893 -7.1% -7.2% 0.1% 2,198 2,559 -14.1% -13.6% -0.5% SURGICAL US 98 120 -18.9% -18.9% - 236 373 -36.8% -36.8% - Intl 153 180 -14.6% -14.8% 0.2% 409 551 -25.7% -24.8% -0.9% WW 251 299 -16.3% -16.4% 0.1% 645 923 -30.2% -29.6% -0.6% TOTAL MEDICAL DEVICES US 3,092 3,057 1.2% 1.2% - 7,852 9,249 -15.1% -15.1% - Intl 3,058 3,326 -8.1% -8.5% 0.4% 8,518 10,082 -15.5% -14.1% -1.4% WW 6,150 $ 6,383 -3.6% -3.9% 0.3% 16,370 $ 19,331 -15.3% -14.6% -0.7% * Percentage greater than 100% or not meaningful (6) Reported as U.S. sales (1) Operational growth excludes the effect of translational currency (7) Previously referred to as Spine & Other (2) Unaudited (3) Previously referred to as Consumer (4) Previously referred to as Beauty (5) Certain prior year amounts have been reclassified to conform to current year product disclosures Note: Columns and rows within tables may not add due to rounding. Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely. % Change % Change -- 4 of 4 --